Announcing a randomized controlled double-blind clinical trial of the LifeWave X39 patch. The non-transdermal phototherapy patch appears to strengthens specific frequencies of the body to increase production of two tri-peptides. The body then uses the peptide GHK to reset 4000 genes in the body and GHK-Cu to stimulate the production of stem cells (Pickard, 1973). This study seeks to determine if the current data on levels of GHK and GHK-Cu production are similar in repeated trials and how long the effects last.
Men and woman age 40-81 with no major medical issues are eligible for this 60 day study. Participants will come into the lab to be consented and on day 1,7, 30 and 60 have their blood drawn. Participants will wear a fresh new non-transdermal patch for 8-12 hours each day for the first 30 days. As a thank you participants who complete the study will receive a one month supply of patches and a $50.00 stipend. Parking is available free and visits will take no more than 30 min.
Ethics approval # NAOEP3-30-22-3
For more information please contact:
Erin Pata
Urgent Care Now
60 Barrett Drive, Suite A
Webster, NY 14580
Discussion
By posting you agree to the Terms and Privacy Policy.